Skip to main content
Erschienen in: Infection 5/2014

01.10.2014 | Clinical and Epidemiological Study

Intensive care unit-acquired blood stream infections: a 5-year retrospective analysis of a single tertiary care hospital in Korea

verfasst von: S. J. Lim, J. Y. Choi, S. J. Lee, Y. J. Cho, Y. Y. Jeong, H. C. Kim, J. D. Lee, Y. S. Hwang

Erschienen in: Infection | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Bloodstream infections (BSIs) are serious complications with high mortality and morbidity in patients with critical illness. This study was conducted to analyze the clinical and microbiological characteristics as well as outcomes in patients with intensive care unit (ICU)-acquired BSIs.

Methods

Data from 1,545 patients admitted to the ICU were retrospectively collected from January 2005 to December 2010. ICU-acquired BSI was defined as a positive blood culture for a clinically significant bacterial or fungal pathogen obtained >72 h after admission to the ICU. Data on clinical and demographic characteristics, comorbid illness, causes of infections, causative pathogens, and clinical outcomes were analyzed.

Results

Among the 1,545 ICU patients analyzed, 129 ICU-acquired BSIs occurred in 124 patients. Catheter-related BSIs (CR-BSIs) and ventilator-associated pneumonia (VAP) were the most common causes (29.4 and 20.9 %, respectively). The most common isolates were Staphylococcus aureus in 35 (25.7 %) and Candida species in 32 (24.8 %) cases. Ninety-eight patients died (overall hospital mortality rate, 75.9 %). ICU-acquired BSI-related mortality occurred in 23 (63.8 %) and 7 (19.4 %) of the VAP and CR-BSIs cases, respectively. The most commonly isolated microorganisms from these fatalities were S. aureus (12, 25.7 %) and Acinetobacter species (12, 25.7 %). In 99 ICU-acquired BSI cases, patients did not receive adequate empirical antimicrobial treatment at the onset of BSIs, whereas the patients in 30 cases did.

Conclusion

ICU-acquired BSIs may be associated with high mortality in patients with critical illness. Meticulous infection control and adequate treatment may reduce ICU-acquired BSI-related mortality.
Literatur
1.
Zurück zum Zitat Barsanti MC, Woeltje KF. Infection prevention in the intensive care unit. Infect Dis Clin North Am. 2009;23:703–25.PubMedCrossRef Barsanti MC, Woeltje KF. Infection prevention in the intensive care unit. Infect Dis Clin North Am. 2009;23:703–25.PubMedCrossRef
2.
Zurück zum Zitat Donowitz LG, Wenzel RP, Hoyt JW. High risk of hospital-acquired infection in the ICU patient. Crit Care Med. 1982;10:355–7.PubMedCrossRef Donowitz LG, Wenzel RP, Hoyt JW. High risk of hospital-acquired infection in the ICU patient. Crit Care Med. 1982;10:355–7.PubMedCrossRef
3.
Zurück zum Zitat Weinstein RA. Epidemiology and control of nosocomial infections in adult intensive care units. Am J Med. 1991;91:179S–84S.PubMedCrossRef Weinstein RA. Epidemiology and control of nosocomial infections in adult intensive care units. Am J Med. 1991;91:179S–84S.PubMedCrossRef
4.
Zurück zum Zitat Wenzel RP, Thompson RL, Landry SM, Russell BS, Miller PJ, Ponce de Leon S, et al. Hospital-acquired infections in intensive care unit patients: an overview with emphasis on epidemics. Infect Control. 1983;4:371–5.PubMed Wenzel RP, Thompson RL, Landry SM, Russell BS, Miller PJ, Ponce de Leon S, et al. Hospital-acquired infections in intensive care unit patients: an overview with emphasis on epidemics. Infect Control. 1983;4:371–5.PubMed
5.
Zurück zum Zitat Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309–17.PubMedCrossRef Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309–17.PubMedCrossRef
6.
Zurück zum Zitat Arya SC, Agarwal N. Nosocomial infections in adult intensive-care units. Lancet. 2003;362:493–4.PubMedCrossRef Arya SC, Agarwal N. Nosocomial infections in adult intensive-care units. Lancet. 2003;362:493–4.PubMedCrossRef
7.
Zurück zum Zitat Valles J, Leon C, Alvarez-Lerma F. Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC). Clin Infect Dis. 1997;24:387–95.PubMedCrossRef Valles J, Leon C, Alvarez-Lerma F. Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC). Clin Infect Dis. 1997;24:387–95.PubMedCrossRef
8.
Zurück zum Zitat Garrouste-Orgeas M, Timsit JF, Tafflet M, Misset B, Zahar JR, Soufir L, et al. Excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: a reappraisal. Clin Infect Dis. 2006;42:1118–26.PubMedCrossRef Garrouste-Orgeas M, Timsit JF, Tafflet M, Misset B, Zahar JR, Soufir L, et al. Excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: a reappraisal. Clin Infect Dis. 2006;42:1118–26.PubMedCrossRef
9.
Zurück zum Zitat Renaud B, Brun-Buisson C. Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med. 2001;163:1584–90.PubMedCrossRef Renaud B, Brun-Buisson C. Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med. 2001;163:1584–90.PubMedCrossRef
10.
Zurück zum Zitat Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323–9.PubMedCrossRef Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323–9.PubMedCrossRef
11.
Zurück zum Zitat Kim JM, Park ES, Jeong JS, Kim KM, Oh HS, Yoon SW, et al. Multicenter surveillance study for nosocomial infections in major hospitals in Korea. Nosocomial Infection Surveillance Committee of the Korean Society for Nosocomial Infection Control. Am J Infect Control. 2000;28:454–8.PubMedCrossRef Kim JM, Park ES, Jeong JS, Kim KM, Oh HS, Yoon SW, et al. Multicenter surveillance study for nosocomial infections in major hospitals in Korea. Nosocomial Infection Surveillance Committee of the Korean Society for Nosocomial Infection Control. Am J Infect Control. 2000;28:454–8.PubMedCrossRef
12.
Zurück zum Zitat Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med. 1999;160:976–81.PubMedCrossRef Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med. 1999;160:976–81.PubMedCrossRef
13.
Zurück zum Zitat Prowle JR, Echeverri JE, Ligabo EV, Sherry N, Taori GC, Crozier TM, et al. Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality. Crit Care. 2011;15:R100.PubMedCrossRefPubMedCentral Prowle JR, Echeverri JE, Ligabo EV, Sherry N, Taori GC, Crozier TM, et al. Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality. Crit Care. 2011;15:R100.PubMedCrossRefPubMedCentral
14.
Zurück zum Zitat Kwak YG, Cho YK, Kim JY, Lee SO, Kim HY, Kim YK, et al. Korean Nosocomial Infections Surveillance System, Intensive Care Unit Module Report: data Summary from July 2008 through June 2009 and Analysis of 3-Year Results. Korean J Nosocomial Infect Control. 2010;15:14–25. Kwak YG, Cho YK, Kim JY, Lee SO, Kim HY, Kim YK, et al. Korean Nosocomial Infections Surveillance System, Intensive Care Unit Module Report: data Summary from July 2008 through June 2009 and Analysis of 3-Year Results. Korean J Nosocomial Infect Control. 2010;15:14–25.
15.
Zurück zum Zitat Pai H. Nosocomial infections in intensive care unit: epidemiology and control strategy. Hanyang Med Rev. 2011;31:153–8.CrossRef Pai H. Nosocomial infections in intensive care unit: epidemiology and control strategy. Hanyang Med Rev. 2011;31:153–8.CrossRef
16.
Zurück zum Zitat Park ES, Jin HY, Jeong SY, Kweon OM, Yoo SY, Park SY, et al. Healthcare-associated infection surveillance in small and medium sized hospitals. Korean J Nosocomial Infect Control. 2011;16:54–62. Park ES, Jin HY, Jeong SY, Kweon OM, Yoo SY, Park SY, et al. Healthcare-associated infection surveillance in small and medium sized hospitals. Korean J Nosocomial Infect Control. 2011;16:54–62.
17.
Zurück zum Zitat Jeon MH, Park WB, Kim SR, Chun HK, Han SH, Bang JH, et al. Korean Nosocomial Infections Surveillance System, Intensive Care Unit Module Report: data Summary from July 2010 through June 2011. Korean J Nosocomial Infect Control. 2012;17:28–39. Jeon MH, Park WB, Kim SR, Chun HK, Han SH, Bang JH, et al. Korean Nosocomial Infections Surveillance System, Intensive Care Unit Module Report: data Summary from July 2010 through June 2011. Korean J Nosocomial Infect Control. 2012;17:28–39.
18.
Zurück zum Zitat Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128–40.PubMedCrossRef Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128–40.PubMedCrossRef
19.
Zurück zum Zitat Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309–32.PubMedCrossRef Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309–32.PubMedCrossRef
20.
Zurück zum Zitat Ding JG, Sun QF, Li KC, Zheng MH, Miao XH, Ni W, et al. Retrospective analysis of nosocomial infections in the intensive care unit of a tertiary hospital in China during 2003 and 2007. BMC Infect Dis. 2009;9:115.PubMedCrossRefPubMedCentral Ding JG, Sun QF, Li KC, Zheng MH, Miao XH, Ni W, et al. Retrospective analysis of nosocomial infections in the intensive care unit of a tertiary hospital in China during 2003 and 2007. BMC Infect Dis. 2009;9:115.PubMedCrossRefPubMedCentral
21.
Zurück zum Zitat Hong SK, Hong SB, Lim CM, Koh Y. The characteristics and prognostic factors of severe sepsis in patients who were admitted to a medical intensive care unit of a tertiary hospital. Korean J Crit Care Med. 2009;24:28–32.CrossRef Hong SK, Hong SB, Lim CM, Koh Y. The characteristics and prognostic factors of severe sepsis in patients who were admitted to a medical intensive care unit of a tertiary hospital. Korean J Crit Care Med. 2009;24:28–32.CrossRef
22.
Zurück zum Zitat Laupland KB, Kirkpatrick AW, Church DL, Ross T, Gregson DB. Intensive-care-unit-acquired bloodstream infections in a regional critically ill population. J Hosp Infect. 2004;58:137–45.PubMedCrossRef Laupland KB, Kirkpatrick AW, Church DL, Ross T, Gregson DB. Intensive-care-unit-acquired bloodstream infections in a regional critically ill population. J Hosp Infect. 2004;58:137–45.PubMedCrossRef
23.
Zurück zum Zitat Gastmeier P, Sohr D, Geffers C, Behnke M, Daschner F, Ruden H. Mortality risk factors with nosocomial Staphylococcus aureus infections in intensive care units: results from the German Nosocomial Infection Surveillance System (KISS). Infection. 2005;33:50–5.PubMedCrossRef Gastmeier P, Sohr D, Geffers C, Behnke M, Daschner F, Ruden H. Mortality risk factors with nosocomial Staphylococcus aureus infections in intensive care units: results from the German Nosocomial Infection Surveillance System (KISS). Infection. 2005;33:50–5.PubMedCrossRef
24.
Zurück zum Zitat Chen R, Yan ZQ, Feng D, Luo YP, Wang LL, Shen DX. Nosocomial bloodstream infection in patients caused by Staphylococcus aureus: drug susceptibility, outcome, and risk factors for hospital mortality. Chin Med J (Engl). 2012;125:226–9. Chen R, Yan ZQ, Feng D, Luo YP, Wang LL, Shen DX. Nosocomial bloodstream infection in patients caused by Staphylococcus aureus: drug susceptibility, outcome, and risk factors for hospital mortality. Chin Med J (Engl). 2012;125:226–9.
25.
Zurück zum Zitat Marra AR, Camargo LF, Pignatari AC, Sukiennik T, Behar PR, Medeiros EA, et al. Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study. J Clin Microbiol. 2011;49:1866–71.PubMedCrossRefPubMedCentral Marra AR, Camargo LF, Pignatari AC, Sukiennik T, Behar PR, Medeiros EA, et al. Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study. J Clin Microbiol. 2011;49:1866–71.PubMedCrossRefPubMedCentral
26.
Zurück zum Zitat Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462–74.PubMedCrossRef Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462–74.PubMedCrossRef
27.
Zurück zum Zitat Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000;118:146–55.PubMedCrossRef Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000;118:146–55.PubMedCrossRef
28.
Zurück zum Zitat Zaragoza R, Artero A, Camarena JJ, Sancho S, Gonzalez R, Nogueira JM. The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin Microbiol Infect. 2003;9:412–8.PubMedCrossRef Zaragoza R, Artero A, Camarena JJ, Sancho S, Gonzalez R, Nogueira JM. The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin Microbiol Infect. 2003;9:412–8.PubMedCrossRef
29.
Zurück zum Zitat Osmon S, Ward S. Fraser VJ, Kollef MH: hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa. Chest. 2004;125:607–16.PubMedCrossRef Osmon S, Ward S. Fraser VJ, Kollef MH: hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa. Chest. 2004;125:607–16.PubMedCrossRef
30.
Zurück zum Zitat Sreeramoju P. Preventing healthcare-associated infections: beyond best practice. Am J Med Sci. 2013;345:239–44.PubMedCrossRef Sreeramoju P. Preventing healthcare-associated infections: beyond best practice. Am J Med Sci. 2013;345:239–44.PubMedCrossRef
Metadaten
Titel
Intensive care unit-acquired blood stream infections: a 5-year retrospective analysis of a single tertiary care hospital in Korea
verfasst von
S. J. Lim
J. Y. Choi
S. J. Lee
Y. J. Cho
Y. Y. Jeong
H. C. Kim
J. D. Lee
Y. S. Hwang
Publikationsdatum
01.10.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 5/2014
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-014-0651-z

Weitere Artikel der Ausgabe 5/2014

Infection 5/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

10.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Mit Capsaicin-Pflastern steht eine neue innovative Therapie bei schmerzhafter diabetischer Polyneuropathie zur Verfügung. Bei therapierefraktären Schmerzen stellt die Hochfrequenz-Rückenmarkstimulation eine adäquate Option dar.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.